Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease

This publication has 39 references indexed in Scilit:

• Angiogenic inhibitors: a new therapeutic strategy in oncology
  Nature Clinical Practice Oncology, 2005
• Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets
  International Journal of Gynecological Cancer, 2005
• Macrophage Colony-Stimulating Factor Induces Vascular Endothelial Growth Factor Production in Skeletal Muscle and Promotes Tumor Angiogenesis
  The Journal of Immunology, 2005
• The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma
  Gynecologic Oncology, 2005
• Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers
  Annals of Oncology, 2005
• Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice
  Cancer Research, 2004
• Expression of vascular endothelial growth factor (VEGF)‐C and VEGF‐D, and their receptor VEGFR‐3, during different stages of cervical carcinogenesis
  The Journal of Pathology, 2003
• The effect of cyclooxygenase‐2 expression on tumor vascularity in advanced stage ovarian serous carcinoma
  Cancer, 2003
• Angiogenesis in histologically benign squamousmucosa is a sensitive marker for nearbycervical intraepithelial neoplasia
  Angiogenesis, 1998
• Vascular Permeability Factor (Vascular Endothelial Growth Factor) Expression and Angiogenesis in Cervical Neoplasia
  JNCI: Journal of the National Cancer Institute, 1995